Aspirin is used to mitigate the increasing frequency of marathon-related cardiac arrests

Article Sidebar

Journal of Cardiovascular Medicine and Cardiology volume9-issue4 articles
PDF HTML
Submitted: November 17, 2022
Published: Dec 15, 2022
DOI: 10.17352/2455-2976.000189
Keywords:
Cardiac troponin, Aspirin, Cardiac arrest, Atherothrombosis, Primary cardiovascular prevention

Main Article Content

Arthur J Siegel*
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA

Downloads

Download data is not yet available.

Article Details

Siegel, A. J. (2022). Aspirin is used to mitigate the increasing frequency of marathon-related cardiac arrests. Journal of Cardiovascular Medicine and Cardiology, 9(4), 077–078. https://doi.org/10.17352/2455-2976.000189
Opinions

Copyright (c) 2022 Siegel AJ.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Kim JH, Malhotra R, Chiampas G, d'Hemecourt P, Troyanos C, Cianca J, Smith RN, Wang TJ, Roberts WO, Thompson PD, Baggish AL; Race Associated Cardiac Arrest Event Registry (RACER) Study Group. Cardiac arrest during long-distance running races. N Engl J Med. 2012 Jan 12;366(2):130-40. doi: 10.1056/NEJMoa1106468. PMID: 22236223.

Siegel AJ, Lewandrowski EL, Chun KY, Sholar MB, Fischman AJ, Lewandrowski KB. Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. Am J Cardiol. 2001 Oct 15;88(8):920-3. doi: 10.1016/s0002-9149(01)01910-5. PMID: 11676966.

Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, Gaze D, Thompson PD. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010 Jul 13;56(3):169-76. doi: 10.1016/j.jacc.2010.03.037. PMID: 20620736.

Sagris M, Antonopolos AA, Antoniadis CA, Tousoulis DT. High-sensitivity troponin (hs-cTn) for cardiovascular risk prognostication: a systematic review and meta-analysis. Eur Heart J. Oct 2022. DOI;10.1093/eurheartj/ehac544.2287.

Ferencik M, Mayrhofer T, Lu MT, Bittner DO, Emami H, Puchner SB, Meyersohn NM, Ivanov AV, Adami EC, Voora D, Ginsburg GS, Januzzi JL, Douglas PS, Hoffmann U. Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results. JACC Cardiovasc Imaging. 2022 Aug;15(8):1427-1438. doi: 10.1016/j.jcmg.2022.03.016. Epub 2022 May 11. PMID: 35926901; PMCID: PMC9353061.

Siegel AJ. Aspirin Use to Reduce the Risk of Sports-Related Cardiac Arrest in High-Risk Athletes. Am J Med. 2019 Mar;132(3):e527-e528. doi: 10.1016/j.amjmed.2018.11.042. PMID: 30827346.

Siegel AJ. Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking? Open Heart. 2015 Jul 2;2(1):e000102. doi: 10.1136/openhrt-2014-000102. PMID: 26167288; PMCID: PMC4493166.

Skadberg Ø, Kleiven Ø, Bjørkavoll-Bergseth M, Melberg T, Bergseth R, Selvåg J, Auestad B, Greve OJ, Dickstein K, Aarsland T, Ørn S. Highly increased Troponin I levels following high-intensity endurance cycling may detect subclinical coronary artery disease in presumably healthy leisure sport cyclists: The North Sea Race Endurance Exercise Study (NEEDED) 2013. Eur J Prev Cardiol. 2017 May;24(8):885-894. doi: 10.1177/2047487317693130. Epub 2017 Feb 10. PMID: 28186443.

Aengevaeren VL, Hopman MTE, Thompson PD, Bakker EA, George KP, Thijssen DHJ, Eijsvogels TMH. Exercise-Induced Cardiac Troponin I Increase and Incident Mortality and Cardiovascular Events. Circulation. 2019 Sep 9;140(10):804-814. doi: 10.1161/CIRCULATIONAHA.119.041627. Epub 2019 Aug 12. PMID: 31401842.

Sung KC, Hong YS, Lee JY, Lee SJ, Chang Y, Ryu S, Zhao D, Cho J, Guallar E, Lima JAC. Physical activity and the progression of coronary artery calcification. Heart. 2021 Nov;107(21):1710-1716. doi: 10.1136/heartjnl-2021-319346. Epub 2021 Sep 20. PMID: 34544807.

Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989 Jul 20;321(3):129-35. doi: 10.1056/NEJM198907203210301. PMID: 2664509.

Lacaze P, Bakshi A, Riaz M, Polekhina G, Owen A, Bhatia HS, Natarajan P, Wolfe R, Beilin L, Nicholls SJ, Watts GF, McNeil JJ, Tonkin AM, Tsimikas S. Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes. J Am Coll Cardiol. 2022 Oct 4;80(14):1287-1298. doi: 10.1016/j.jacc.2022.07.027. Erratum in: J Am Coll Cardiol. 2022 Nov 15;80(20):1963. PMID: 36175048.

Möhlenkamp S, Schmermund A, Kröger K, Kerkhoff G, Bröcker-Preuss M, Adams V, Hensel M, Kiefer D, Lehmann N, Moebus S, Leineweber K, Elsenbruch S, Barkhausen J, Halle M, Hambrecht R, Siegrist J, Mann K, Budde T, Jöckel KH, Erbel R. Coronary atherosclerosis and cardiovascular risk in masters male marathon runners. Rationale and design of the "marathon study". Herz. 2006 Sep;31(6):575-85. doi: 10.1007/s00059-006-2879-6. PMID: 17036189.